Bonus BioGroup Ltd. (TLV:BONS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 21.70
-0.40 (-1.81%)
Jun 5, 2025, 5:24 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 256.94 million as of June 6, 2025. Its market cap has increased by 35.80% in one year.
Market Cap
256.94M
Enterprise Value
260.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
21.70
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 256.94M, an increase of 1,978.39%. That is a compound annual growth rate of 26.58%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 69.40B |
| Danel (Adir Yeoshua) | 2.38B |
| Kamada | 1.36B |
| Bait Bakfar | 1.16B |
| SofWave Medical | 752.54M |
| Novolog (Pharm-Up 1966) | 716.20M |
| Ilex Medical | 693.44M |
| BrainsWay | 689.62M |